Evaluation status available after sign-in
About the journal
BioDrugs is a journal published by Adis, Springer Healthcare in Switzerland. It is listed in MEDLINE and PUBMED according to the sources read. Declared publication charge: 4,690 EUR. Facts are reproduced as recorded at their sources with their capture dates; PublishLens indicators are available after sign-in.
Basic facts
- Publisher
- Adis, Springer Healthcare
- ISSN
- 1173-8804 · 1179-190X
- Country
- Switzerland
- Access
- Not open access / not declared
- Declared publication charge
- 4,690 EUR
- Declared peer-review model
- peer_review
- Official website
- https://www.springer.com/journal/40259
Index listings
- MEDLINE · 2001-01-01
- PUBMED · 2010-02-01
- Indexing
- MEDLINE · PUBMED
- APC
- 4,690 EUR
- Declared review time (DOAJ)
- —
- Activity (OpenAlex)
- Active — latest works 2026
- PublishLens list status
- Shown after sign-in
- Counts for promotion at your university?
- Choose your university and rank below ↓
Methodology signals (dated facts from their sources)
Details of the evaluation under the published methodology are shown to signed-in users (free).
Create a free account to view the evaluationJournal profile
Descriptive metadata from public sources (DOAJ, OpenAlex, PubMed) as of the capture date shown — contains no assessment or judgment.
Works in OpenAlex
1710
Last recorded publication year
2026
Reported by OpenAlex in 1 of 3 sources (CC0 flags, not verified indexing)DOAJSciELOOpenAlex Core
h-index
99
i10-index
1010
From OpenAlex open data (CC0).
Editorial & policy6
- Observed digital preservation (Keepers registry)— snapshot 2026-10-05
- CLOCKSSPortico
- Editorial board
- Official page ↗
- Norwegian register (HK-dir)— 2026
- Level 1 — approved scholarly channel
- Open references deposited at Crossref
- 95%
- ORCID iDs in current deposits
- 82%
- Enrolled in Crossref Similarity Check
- ✓
- Deposits licence metadata at Crossref
- ✓
Identity & continuity3
- Alternate titles
- Bio Drugs
- Source type
- journal
- NLM unique ID (PubMed)
- 9705305
Classification(no data)
No data available to the platform for this group
No platform data for: Classification — absence is not a judgment about the journal.
Subject areas
- Biosimilars and Bioanalytical Methods
- Biosimilars and Bioanalytical Methods
- Biosimilars and Bioanalytical Methods
- Monoclonal and Polyclonal Antibodies Research
- Monoclonal and Polyclonal Antibodies Research
- Monoclonal and Polyclonal Antibodies Research
- Rheumatoid Arthritis Research and Therapies
- Pharmaceutical Economics and Policy
Show all subjects (75)
- Rheumatoid Arthritis Research and Therapies
- Rheumatoid Arthritis Research and Therapies
- Immunotherapy and Immune Responses
- Immunotherapy and Immune Responses
- Immunotherapy and Immune Responses
- CAR-T cell therapy research
- CAR-T cell therapy research
- Psoriasis: Treatment and Pathogenesis
- Asthma and respiratory diseases
- Inflammatory Bowel Disease
- Cancer Immunotherapy and Biomarkers
- Asthma and respiratory diseases
- Asthma and respiratory diseases
- T-cell and B-cell Immunology
- Protein purification and stability
- Systemic Lupus Erythematosus Research
- Systemic Lupus Erythematosus Research
- Renal Transplantation Outcomes and Treatments
- Transplantation: Methods and Outcomes
- RNA Interference and Gene Delivery
- RNA Interference and Gene Delivery
- Inflammatory Bowel Disease
- Inflammatory Bowel Disease
- RNA Interference and Gene Delivery
- Pharmaceutical Economics and Policy
- Health Systems, Economic Evaluations, Quality of Life
- Pharmaceutical Economics and Policy
- Chronic Lymphocytic Leukemia Research
- Chronic Lymphocytic Leukemia Research
- Virus-based gene therapy research
- Virus-based gene therapy research
- Virus-based gene therapy research
- Protein purification and stability
- Cancer Immunotherapy and Biomarkers
- Protein purification and stability
- Cancer Immunotherapy and Biomarkers
- Natural Compounds in Disease Treatment
- HER2/EGFR in Cancer Research
- Autoimmune and Inflammatory Disorders Research
- HER2/EGFR in Cancer Research
- Ocular Diseases and Behçet’s Syndrome
- Immune Cell Function and Interaction
- Immune Cell Function and Interaction
- Renal Transplantation Outcomes and Treatments
- Renal Transplantation Outcomes and Treatments
- Immunodeficiency and Autoimmune Disorders
- Immunodeficiency and Autoimmune Disorders
- Psoriasis: Treatment and Pathogenesis
- Psoriasis: Treatment and Pathogenesis
- Health Systems, Economic Evaluations, Quality of Life
- Health Systems, Economic Evaluations, Quality of Life
- Pharmacovigilance and Adverse Drug Reactions
- Spondyloarthritis Studies and Treatments
- Autoimmune and Inflammatory Disorders Research
- Autoimmune and Inflammatory Disorders Research
- Spondyloarthritis Studies and Treatments
- T-cell and B-cell Immunology
- T-cell and B-cell Immunology
- Spondyloarthritis Studies and Treatments
- Neutropenia and Cancer Infections
- Lymphoma Diagnosis and Treatment
- Lymphoma Diagnosis and Treatment
- Neutropenia and Cancer Infections
- Dermatology and Skin Diseases
- Bacterial Infections and Vaccines
- Multiple Sclerosis Research Studies
- Nanoparticle-Based Drug Delivery
Community confirmations — what users saw in MJL or Scopus Sources; not platform verification and never part of any score.
Loading community confirmations…
The journal's record in other sources:Web of Science MJLDOAJ